Employers › Aytu Biopharma
Recordkeeping fees per participant · Aytu Biopharma Employee Retirement Plan · plan year 2024
$24.12
Higher than 23% of the 14,075 plans $10 to 50M that report it.
= $5,185 / 215
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250916101908NAL0001121347001, received 2025-09-16
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250916101908NAL0001121347001, received 2025-09-16
Percentiles compare this plan with the Schedule H plans $10 to 50M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-09-16.
Administrative expenses excluding investment management, per participant
$24.12
Higher than 15% of the 24,371 plans $10 to 50M that report it.
= $5,185 / 215
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250916101908NAL0001121347001, received 2025-09-16
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250916101908NAL0001121347001, received 2025-09-16
Administrative expenses per participant
$231.79
Higher than 58% of the 25,098 plans $10 to 50M that report it.
= $49,834 / 215
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250916101908NAL0001121347001, received 2025-09-16
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250916101908NAL0001121347001, received 2025-09-16
Administrative expenses as a share of assets
0.314%
Higher than 55% of the 25,132 plans $10 to 50M that report it.
= $49,834 / $15,859,006
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250916101908NAL0001121347001, received 2025-09-16
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250916101908NAL0001121347001, received 2025-09-16
Employer contributions per participant
$2,863
Higher than 70% of the 24,050 plans $10 to 50M that report it.
= $615,552 / 215
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250916101908NAL0001121347001, received 2025-09-16
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250916101908NAL0001121347001, received 2025-09-16
Employer share of total contributions
31.1%
Higher than 62% of the 24,084 plans $10 to 50M that report it.
= $615,552 / $1,977,940
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250916101908NAL0001121347001, received 2025-09-16
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250916101908NAL0001121347001, received 2025-09-16
Employer match
“The Aytu 401(k) Plan matches 100% of the first 3% contributed by employees and matches 50% of the next 4% and 5% contributed by employees.”
Form 10-K filed 2025-09-23, for the year ended 2025-06-30 · benefits note, 10-K benefits note · source document
Terms quoted from the filing for the year ended 2025-06-30. Figures cover plan year 2024. The plan document governs.
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2S pre-approved plan document · 2T default investment (QDIA) · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250916101908NAL0001121347001, received 2025-09-16
| Field | Value | Source |
|---|---|---|
| Plan sponsor | AYTU BIOPHARMA, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Plan name | AYTU BIOPHARMA EMPLOYEE RETIREMENT PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Sponsor EIN / plan number | 47-0883144 / 002 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Sponsor location | DENVER, CO | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Industry (business code) | 325410, Manufacturing | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Filing received | 2025-09-16 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Participants, beginning of year | 242 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Active participants | 94 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Participants, end of year | 218 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Participants with an account balance | 215 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Total assets, beginning of year | $15,415,462 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Total assets, end of year | $15,859,006 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Net assets, end of year | $15,859,006 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Total income | $3,875,088 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Net income | $443,544 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Employer contributions | $615,552 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Participant contributions | $1,202,645 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Other contributions (incl. rollovers) | $159,743 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Total contributions | $1,977,940 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Benefit payments | $3,381,710 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Total expenses (incl. benefit payments) | $3,431,544 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Total administrative expenses | $49,834 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Recordkeeping fees | $5,185 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Investment advisory and management fees | $44,649 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Administrative expenses excluding investment management | $5,185 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Held in common/collective trusts | $152,156 | Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Held in mutual funds | $15,535,994 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250916101908NAL0001121347001, received 2025-09-16 |
| Independent auditor | WEAVER AND TIDWELL, LLP | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250916101908NAL0001121347001, received 2025-09-16 |
Position = column in the DOL layout for form year 2024. Filing 20250916101908NAL0001121347001, received 2025-09-16.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| BRYANT & BRANNOCK LLC | NONE | 27 Investment advisory (plan); 50 Direct payment from the plan | $44,649 | no |
| T ROWE PRICE RPS INCrecordkeeper | NONE | 15 Recordkeeping and information management; 21 Trustee (bank, trust company or similar); 25 Trustee (directed); 28 Investment management; 37 Participant loan processing; 38 Participant communication; 49 Other services; 50 Direct payment from the plan; 52 Investment management fees paid indirectly by plan; 59 Shareholder servicing fees; 62 Float revenue; 64 Recordkeeping fees; 65 Account maintenance fees | $5,185 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250916101908NAL0001121347001, received 2025-09-16.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $15,415,462 | $15,859,006 | 2.9% |
| Participants with a balance | 234 | 215 | -8.1% |
| Administrative expenses | $37,467 | $49,834 | 33.0% |
| Recordkeeping fees per participant | $6.91 | $24.12 | 249.0% |
| Employer contributions | $717,565 | $615,552 | -14.2% |
Prior filing 20241014125624NAL0014957059001, received 2024-10-14; the plan years are contiguous.
Sponsor name as filed: AYTU BIOPHARMA, INC.; SEC registrant: AYTU BIOPHARMA, INC (CIK 1385818, matched by EIN; display name from the Form 10-K cover).